Xiaofan Lu

14PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 22, 2026
MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa.

|Oct 08, 2025
Racial differences in kidney cancer histology and outcome: A nationwide study from the UroCCR Cohort.

Xiaofan Lu, Jean-Christophe Bernhard, Gaëlle Margue

|Jan 23, 2025
Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma.

Xiaofan Lu, Yann-Alexandre Vano, Xiaoping Su

|Jun 13, 2024
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.

Jialin Meng, Aimin Jiang, Xiaofan Lu

|Mar 06, 2024
MOVICShiny: An interactive website for multi-omics integration and visualisation in cancer subtyping.

Junkai Zhu, Yuyao Zhu, Xin Wang

|Nov 30, 2023
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.

Xiaoping Su, Xiaofan Lu, Sehrish Khan Bazai

Pageof 3

Frequent Collaborators

10 joint publications

Fangrong Yan

6 joint publications

Gabriel G Malouf

5 joint publications

Jialin Meng

2 joint publications

Wolf Hervé Fridman